Skip to main content

Raphael Pharmaceutical Inc. (RAPH) Stock Forecast 2025 - AI Price Prediction & Analysis


Raphael Pharmaceutical Inc. (RAPH) AI Stock Price Forecast & Investment Analysis

Raphael Pharmaceutical Inc. Stock Price Chart and Technical Analysis

Loading Raphael Pharmaceutical Inc. interactive price chart and technical analysis...

Raphael Pharmaceutical Inc. (RAPH) - Comprehensive Stock Analysis & Investment Research

Deep dive into Raphael Pharmaceutical Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Raphael Pharmaceutical Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Raphael Pharmaceutical Inc.: Raphael Pharmaceutical Inc. operates in the Life Sciences sector, making it an emerging small-cap investment.

Raphael Pharmaceutical Inc. (Stock Symbol: RAPH) is a leading company in the Life Sciences sector , specifically operating within the Medicinal Chemicals & Botanical Products industry.

.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Raphael Pharmaceutical Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Raphael Pharmaceutical Inc.:

Market Capitalization: $4 million - Classified as a small-cap investment offering high growth potential.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Raphael Pharmaceutical Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Raphael Pharmaceutical Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Raphael Pharmaceutical Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Raphael Pharmaceutical Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Raphael Pharmaceutical Inc.: Market positioning analysis based on available financial and operational metrics.

Raphael Pharmaceutical Inc. strategically competes in the highly dynamic Medicinal Chemicals & Botanical Products marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

Raphael Pharmaceutical Inc. (RAPH) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Raphael Pharmaceutical Inc. stock analysis.

Loading Raphael Pharmaceutical Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Raphael Pharmaceutical Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Raphael Pharmaceutical Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Raphael Pharmaceutical Inc.:

Market Cap $4M
EPS $0.08
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Raphael Pharmaceutical Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Raphael Pharmaceutical Inc.:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess Raphael Pharmaceutical Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Raphael Pharmaceutical Inc.:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Raphael Pharmaceutical Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Raphael Pharmaceutical Inc.:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Raphael Pharmaceutical Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Raphael Pharmaceutical Inc.:

Understanding Financial Statement Data

What these metrics mean: Key figures from Raphael Pharmaceutical Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Raphael Pharmaceutical Inc.:

Income Statement ($ Millions)
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 20M

Latest Raphael Pharmaceutical Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Raphael Pharmaceutical Inc. (RAPH) stock price and investment outlook.

, source: Yahoo Finance

NEW YORK, July 09, 2024 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH), a clinical-stage biotechnology company advancing a novel ...

, source: NJBIZ

Rafael Holdings Inc. in Newark and Rafael Pharmaceuticals Inc. in Cranbury entered into an agreement to merge into one late-stage clinical oncology company focused on cancer metabolism-based ...

Raphael Pharmaceutical Inc. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Raphael Pharmaceutical Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAWH Unlock Forecast - 30 Days FREE Trial $153M x 5.6x
AIBT Unlock Forecast - 30 Days FREE Trial $0M x x
AYRWF Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BTMD Unlock Forecast - 30 Days FREE Trial $388M 15.7x -3.0x
CBDY Unlock Forecast - 30 Days FREE Trial $1M x x
CDXC Unlock Forecast - 30 Days FREE Trial $536M -666.2x 11.6x
CGC Unlock Forecast - 30 Days FREE Trial $202M -0.3x 0.4x
CRON Unlock Forecast - 30 Days FREE Trial $1015M 54.9x 0.9x
CURLF Unlock Forecast - 30 Days FREE Trial $2647M x 3.1x
CXXIF Unlock Forecast - 30 Days FREE Trial $41M x 1.4x
CYAN Unlock Forecast - 30 Days FREE Trial $2M -0.5x 0.3x
FTLF Unlock Forecast - 30 Days FREE Trial $120M 19.3x 3.1x
GHBWF Unlock Forecast - 30 Days FREE Trial $37M x 0.3x
GLASF Unlock Forecast - 30 Days FREE Trial $811M x 7.0x
GLUC Unlock Forecast - 30 Days FREE Trial $0M x x
JUSHF Unlock Forecast - 30 Days FREE Trial $141M x x
MNMD Unlock Forecast - 30 Days FREE Trial $803M -3.1x 4.3x
MTEX Unlock Forecast - 30 Days FREE Trial $18M -55.4x 2.4x
NAGE Unlock Forecast - 30 Days FREE Trial $799M 45.1x 12.4x
NAII Unlock Forecast - 30 Days FREE Trial $26M -3.3x 0.3x
RAJAF Unlock Forecast - 30 Days FREE Trial $1020M x x
RAPH Unlock Forecast - 30 Days FREE Trial $4M x x
SMFL Unlock Forecast - 30 Days FREE Trial $0M 0.0x 0.0x
SNYR Unlock Forecast - 30 Days FREE Trial $33M -551.3x -2.1x
TCNNF Unlock Forecast - 30 Days FREE Trial $1448M x 1.2x
TCRG Unlock Forecast - 30 Days FREE Trial $16M x x
TLRY Unlock Forecast - 30 Days FREE Trial $684M -4.1x 0.3x
UPXI Unlock Forecast - 30 Days FREE Trial $279M -10.6x 150.7x
USNA Unlock Forecast - 30 Days FREE Trial $570M 13.6x 1.1x

Frequently Asked Questions - Raphael Pharmaceutical Inc. Stock Forecast

How accurate are Raphael Pharmaceutical Inc. stock predictions?

Our AI model demonstrates 23% historical accuracy for RAPH predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Raphael Pharmaceutical Inc. stock price forecasts?

Our analysis considers Raphael Pharmaceutical Inc.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Raphael Pharmaceutical Inc. a good investment in 2025?

Based on our AI analysis, Raphael Pharmaceutical Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Raphael Pharmaceutical Inc. forecasts updated?

Raphael Pharmaceutical Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Raphael Pharmaceutical Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Raphael Pharmaceutical Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...